Midatech Pharma Investor Presentation — September 2020

Document content

10 September 2020The Midatech senior team

Director Business Development

VP Pharmaceutical & Technology Development

The following presentation, including ahard copy ofthese slides/the talks given bythepresenters, theinformation communicated during anydelivery ofthepresentation and any question and answer session and any

document ormaterial distributed atorinconnection with thepresentation (together, the“Presentation”), hasbeen prepared byMidatech Pharma PLC(the“Company”) inconnection with aproposed offering ofsecurities of

theCompany (the“Offering”) .Theinformation inthePresentation isnotintended toform thebasis ofanycontract .

ThePresentation does notconstitute orform part ofanoffer orinvitation toissue orsell, orthesolicitation ofanoffer tosubscribe orpurchase, anysecurities toanyperson inanyjurisdiction towhom orinwhich such offer

orsolicitation isunlawful .

Thedistribution ofthisPresentation may, incertain jurisdictions, berestricted bylaw.Persons inpossession ofthisPresentation arerequired toinform themselves about andtoobserve anysuch restrictions .Noaction hasbeen

taken orwillbetaken inanyjurisdiction bytheCompany that would permit thepossession ordistribution ofanydocuments oranyamendment orsupplement thereto (including butnotlimited tothisPresentation) inanycountry

orjurisdiction where specific action forthat purpose isrequired .

This Presentation does notconstitute anoffer orsolicitation topurchase orsubscribe forsecurities intheUnited States .Thesecurities oftheCompany towhich thePresentation relates have notbeen registered, andwillnot

beregistered, under theU.S.Securities Actof1933 ,asamended (the“Securities Act”), orunder thesecurities laws ofanystate orother jurisdiction oftheUnited States and may notbeoffered orsold intheUnited States